温馨提示：本站仅提供公开网络链接索引服务，不存储、不篡改任何第三方内容，所有内容版权归原作者所有
AI智能索引来源：http://www.fr.com/insights/webinars/biosimilars-2019-mid-year-update
点击访问原文链接

Biosimilars 2019 Mid-Year Update | Fish

进入原网站 导航首页
Why FishDiversity, Equity & InclusionPro Bono & Social ResponsibilityLegal OperationsPricingLegal Project ManagementKnowledge ManagementeDiscoveryLegal Technology ServicesOur PeopleServicesLitigationPatent LitigationTrademark, Copyright & Media LitigationTrade Secret LitigationAppellateITC Litigation & Section 337Standard Essential PatentsChancery & Corporate GovernancePost-GrantInter Partes ReviewPost-Grant ReviewEx Parte ReexaminationSupplemental ExaminationPatentPatent ProsecutionStrategic Patent Counseling & OpinionsPatent Portfolio ManagementUnitary Patent & Unified Patent CourtIP Licensing, Transactions & AgreementsTrademark & Copyright Counseling & ProsecutionStrategic Counseling, Registration & OpinionsAdvertising & MarketingDomain Names & InternetTTAB Oppositions & CancellationsDigital Millennium Copyright ActTransactions & AgreementsRegulatory & Government AffairsCommunications & Spectrum RegulationDrug & Medical Device RegulationmHealth & TelemedicinePrivacy & Data SecurityIndustriesElectrical & Computer TechnologySoftware & InternetHardwareSemiconductorsConsumer ElectronicsOpticsArtificial IntelligenceDigital HealthDigital Media & E-CommerceFinancial, Business & FinTech ServicesTelecommunicationsEnergy & ChemicalsPetrochemicalCleantechLife SciencesBiotech & DiagnosticsMedical DevicesPharmaceuticalsAcademic Research & Medical CentersTransportation, Aerospace & DefenseManufacturingAutonomous VehiclesInsightsThought LeadershipIP Law EssentialsPost-Grant Annual ReportsWebinarsPodcastsOfficesCareersNews & EventsContact UsHomeInsightsWebinarsJohn C. Adkisson[email protected]LitigationPatent LitigationPost-GrantRegulatory & Government AffairsDrug & Medical Device RegulationLife SciencesPharmaceuticalsApril 28, 2026 Trade Secrets 101: Protecting Your Competitive Edge and Spotting Misuse Read moreMay 19, 2026 Building the IP Moat: Maximizing Technology Value on the Path to IPO Read moreBlog April 15, 2026 USPTO, DOJ Statement of Interest Supports Injunctive Relief   Read moreBlog April 3, 2026 USPTO to Allow Pre-Order Patent Owner Responses in Reexaminations Read moreBlog March 27, 2026 Congressional Oversight Hearing Highlights Continued PTAB Policy Fault Lines Read moreBlog March 24, 2026 Federal Circuit Denies All Mandamus Petitions Challenging Discretionary Denial Policies Read moreBlog March 17, 2026 The Federal Circuit Continues to Evolve Its Daubert Gatekeeping Framework: Willis and Exafer Read moreBlog March 13, 2026 USPTO Adds Three New Factors to Discretionary Denial Considerations Read moreBlog March 9, 2026 Biologics and Biosimilars Landscape 2025: IP, Policy, and Market Developments Read moreBlog February 24, 2026 The Shifting SEP Litigation Landscape: How Changes in the Types of Litigated SEPs Can Affect Implementers Read moreBlog February 19, 2026 Be Careful What You Wish For: How Stipulations Become Federal Circuit Issues Read moreArticle February 13, 2026 Semiconductor Litigation: Advanced Process Transitions and the Next Wave of Patent Risk Read moreOfficesAtlantaAustinBostonChicagoDallasDelawareHoustonMinneapolisMunichNew YorkOrange CountySan DiegoShenzhenSilicon ValleyWashington, D.C.CareersLife at FishJudicial ClerksLaw StudentsLateral HiresScientists & EngineersOperations & Admin StaffTraining & BenefitsFAQSubscribeContact UsSite MapCookie PolicyDisclaimerPrivacy PolicyTerms of Use

智能索引记录